Submission for podium and poster presentations are due by July 29, 2016. Areas of particular interest for DDL27 include: • Inhalers – were they really meant for humans? • Beyond Asthma and COPD • 60 Years of the pMDI •Innovations in Aerosol Delivery • The Pat Burnell New Investigator Award. Submit abstracts at http://ddl-conference.com/?q=+PosterGuidelines_ddl27
DDL 27
published on
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
